Viridian Therapeutics, Inc.

VRDN ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
4 Mar 28, 2017 FORM 4 SUBMISSION
10-K Mar 24, 2017 FORM 10-K
4 Mar 13, 2017 FORM 4 SUBMISSION
SC 13G Mar 10, 2017
4 Mar 8, 2017 FORM 4 SUBMISSION
SC 13D/A Mar 7, 2017 MIRAGEN SCHEDULE 13DA 3-6-17
4 Feb 28, 2017 FORM 4 SUBMISSION
4 Feb 24, 2017 FORM 4 SUBMISSION
SC 13G/A Feb 24, 2017 MIRAGEN THERAPEUTICS, INC.
SC 13D Feb 24, 2017 SCHEDULE 13D 2-24-17
SC 13D Feb 23, 2017 SC 13D
SC 13G Feb 17, 2017 SC 13G
S-8 Feb 17, 2017 S-8
4 Feb 16, 2017 FORM 4 SUBMISSION
4 Feb 16, 2017 FORM 4 SUBMISSION
4 Feb 16, 2017 FORM 4 SUBMISSION
4 Feb 16, 2017 FORM 4 SUBMISSION
4 Feb 13, 2017 FORM 4 SUBMISSION
3 Feb 13, 2017 FORM 3 SUBMISSION
3 Feb 13, 2017 FORM 3 SUBMISSION
3 Feb 13, 2017 FORM 3 SUBMISSION
3 Feb 13, 2017 FORM 3 SUBMISSION
3 Feb 13, 2017 FORM 3 SUBMISSION
3 Feb 13, 2017 FORM 3 SUBMISSION
3 Feb 13, 2017 FORM 3 SUBMISSION
← Newer Page 26 of 33 · 821 filings Older →